Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Neuropeptide S (NPS) was identified as an endogenous ligand of the orphan receptor GPR154 (also known as GPRA, VRR1) by a reverse pharmacological strategy in 2002, consisting of 20 amino acids. Because its amino-terminal residues are serine (S) in the tested species, it is named neuropeptide S. NPS functions through its receptor NPSR, which is a G protein coupled receptor (GPCR), mainly Gs and Gq proteins. NPS and its receptors constitute a new neuropeptide system that regulates a number of important physiological and pathological processes such as arousal and sleep, anxiety and depression, learning and memory, food and energy metabolism, neuroendocrine, immunity and antioxidant.
Figure 1. Representative scheme of neuronal neuropeptide S receptor (NPSR)-coupled signaling cascades summarizing finding. (Thomas, G., et al. 2018)
NPS Receptor
NPS receptors were originally identified as orphan receptor GPR154, vasopressin receptor-related receptor-1 (VRR1), asthma-susceptible G protein-coupled receptors, and so on. NPSR is a typical G protein-coupled receptor with moderate degree of homology to other peptide receptors. In particular, the vasopressin receptors V1a and V2, but only 21% to 23% of the amino acid residues are the same. After activation of NPSR, Ca2+ increases in cells, indicating that it is mainly an excitatory effect at the cellular level, and cAMP levels in cells are increased, which indicates that the NPSR-coupled G proteins are mainly Gs and Gq proteins.
NPSR mRNA is expressed in stress-related brain regions such as the apricot kernel, hypothalamus, mesial nucleus group, and ventral tegmental area. The NPS system may interact with other neurotransmitters (5-hydroxytryptamine, dopamine, etc.) to regulate anxiety and stress responses. Studies have found that NPSR may regulate the pathophysiology of asthma by increasing expression in the bronchial epithelium and inhibiting cell proliferation. Researchers have explored downstream genes of the NPS-NPSR pathway and found that a series of asthma-related genes have significantly increased expression, such as matrix metallopeptidase 10 (MMP10), inhibin alpha subunit gene (INHBA), and interleukin (IL8), suggesting that the NPS system is involved in the development of asthma.
NPS Physiological Function
NPS and its receptors are widely distributed in the nervous system and various organ tissues, especially NPSR is widely distributed in the central nervous system. Current research shows that NPS has a variety of neurophysiological functions. Moreover, research on the physiological and pharmacological effects of NPS has been extensively carried out, and the spectrum of NPS effects is gradually expanding. With the elucidation of the physiological and pathological effects of the NPS system, NPS has become a promising new drug target in regulating wakefulness and sleep, anti-anxiety, and regulating food intake.
The role of NPS in promoting arousal may be mediated in part by NPSR expressed in the midline nucleus of the thalamus, because this part of the brain area is a relay station between the brainstem arousal center and the cerebral cortex. NPSR mRNA is significantly expressed in several pathways that activate wakefulness, such as expression in multiple mid thalamic nucleus, junctional nucleus, diamond nucleus, and scattered in the plate core group. These regions relay the projection of the brainstem reticular structure into the cortex, which is very important for regulating arousal. In view of this distribution of NPSR, it is speculated that NPS may promote the arousal state of experimental animals and inhibit the sleep behavior of experimental animals by promoting the wake-related brain regions and the GABA-inhibiting neurons in the sleeping brain regions.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.